Walgreens Boots Alliance Inc

-0.81 (-2.13%)
Share Repurchases, Other Pre-Announcement

Walgreens Boots Alliance Posts Q4 EPS Of $0.43

Published: 10/15/2020 13:35 GMT
Walgreens Boots Alliance Inc (WBA) - Q4 EPS 0.43 Usd.
Q4 Sales Rose 2.3 Percent to 34.7 Billion Usd.
Qtrly Sales Increased 2.3 Percent to $34.7 Billion, Up 2.3 Percent on a Constant Currency Basis.
Introduced Fiscal 2021 Guidance of Low Single-digit Growth in Adjusted EPS at Constant Currency Rates.
Q4 Revenue View $34.37 Billion -- Refinitiv Ibes Data (analyst estimates).
First Half 2021 Results Will Continue to Be Negatively Impacted Versus Pre-covid-19 First Half of Fiscal 2020.
Fourth Quarter Sales in Retail Pharmacy USA Increased 3.6% to $27.0 Billion.
Seeing Gradual Improvement in Key U.S. and Uk Markets and Strong Performance in Wholesale Business.
Walgreens Boots Alliance - for H2 2021, Sees Strong Adjusted.
EPS Growth, As Covid-19 Effects Subside, Recovery Plans Take Hold in Key Markets.
Q4 Sales in Comparable Stores for Retail Pharmacy USA Also Increased 3.6 Percent From the Year-ago Quarter.
Walgreens - Completed More Than 1 Million Covid-19 Tests at More Than 440 Sites in 49 States; Increased Testing Capacity to 500,000/month.
Retail Pharmacy International Had Q4 Sales of $2.3 Billion, Decrease of 14.9% From the Year-ago Quarter.
Cost Management Program Remains on Track to Deliver in Excess of $2 Billion in Annual Cost Savings by Fiscal 2022.
More Than 3,500 Walgreens Stores Converted to Retail Sap As of End of Q4.
Qtrly Adjusted Earnings per Share $1.02.
Q4 Earnings per Share View $0.96 -- Refinitiv Ibes Data (analyst estimates).